PDS Biotechnology Corp Working Capital to Net Assets Ratio
PDS Biotechnology Corp working capital to net assets ratio. PDS Biotechnology Corp (PDSB) has a Working Capital to Net Assets ratio of 149.0% as of June 2026. Working capital of $-5.33 Million (current assets of $7.05 Million minus current liabilities of $12.38 Million) is measured against net assets of $-3.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check PDS Biotechnology Corp (PDSB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of PDS Biotechnology Corp (2012–2025)
Working capital to net assets ratio of PDS Biotechnology Corp from 2012 to 2025. This chart shows how PDS Biotechnology Corp's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 149.0%, reflecting working capital of $-5.33 Million against net assets of $-3.58 Million USD. See defensive interval ratio of PDS Biotechnology Corp to measure how many days the company can operate on defensive assets alone.
PDS Biotechnology Corp Working Capital to Net Assets Ratio by Year (2012–2025)
PDS Biotechnology Corp working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for PDS Biotechnology Corp from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see PDS Biotechnology Corp total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 202.9% | $18.77 Million | $9.25 Million | $28.25 Million | $9.48 Million | ▲ +55.7 pp |
| 2024 | 147.2% | $27.97 Million | $19.00 Million | $45.05 Million | $17.09 Million | ▼ -26.7 pp |
| 2023 | 173.8% | $45.43 Million | $26.13 Million | $59.06 Million | $13.63 Million | ▲ +22.3 pp |
| 2022 | 151.5% | $66.66 Million | $44.00 Million | $76.48 Million | $9.82 Million | ▲ +51.7 pp |
| 2021 | 99.8% | $63.08 Million | $63.21 Million | $66.84 Million | $3.76 Million | ▲ +0.0 pp |
| 2020 | 99.8% | $27.07 Million | $27.13 Million | $30.34 Million | $3.27 Million | ▼ -0.1 pp |
| 2019 | 99.8% | $11.68 Million | $11.70 Million | $14.47 Million | $2.79 Million | ▲ +1.7 pp |
| 2018 | 98.1% | $29.27 Million | $29.84 Million | $35.65 Million | $6.38 Million | ▼ -24.1 pp |
| 2017 | 122.2% | $76.19 Million | $62.37 Million | $89.05 Million | $12.87 Million | ▲ +9.4 pp |
| 2016 | 112.8% | $100.67 Million | $89.28 Million | $107.35 Million | $6.68 Million | ▲ +12.6 pp |
| 2015 | 100.2% | $122.68 Million | $122.48 Million | $131.27 Million | $8.59 Million | ▲ +141.7 pp |
| 2014 | -41.5% | $11.55 Million | $-27.83 Million | $15.44 Million | $3.89 Million | ▲ +2.4 pp |
| 2013 | -43.9% | $6.74 Million | $-15.35 Million | $8.53 Million | $1.79 Million | ▼ -143.6 pp |
| 2012 | 99.7% | $-3.37 Million | $-3.38 Million | $147.39K | $3.52 Million | — |